Cargando…

The determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis

In this study, it was aimed to investigate the efficacy of chitosan oligosaccharide administrations in different doses of experimental infected lambs with Cryptosporidium parvum. 32 male lambs were used in the study and the lambs were divided into 4 groups with 8 lambs in each group. Groups 1, 2 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydogdu, Ugur, Coskun, Alparslan, Atas, Ahmet Duran, Basbug, Onur, Agaoglu, Zahid Tevfik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135297/
https://www.ncbi.nlm.nih.gov/pubmed/32288211
http://dx.doi.org/10.1016/j.smallrumres.2019.09.021
_version_ 1783518024255406080
author Aydogdu, Ugur
Coskun, Alparslan
Atas, Ahmet Duran
Basbug, Onur
Agaoglu, Zahid Tevfik
author_facet Aydogdu, Ugur
Coskun, Alparslan
Atas, Ahmet Duran
Basbug, Onur
Agaoglu, Zahid Tevfik
author_sort Aydogdu, Ugur
collection PubMed
description In this study, it was aimed to investigate the efficacy of chitosan oligosaccharide administrations in different doses of experimental infected lambs with Cryptosporidium parvum. 32 male lambs were used in the study and the lambs were divided into 4 groups with 8 lambs in each group. Groups 1, 2 and 3, twice a day, were administered chitosan oligosaccharide at a dose of 100, 500, and 1000 mg/kg for 7 days, respectively, with milk replacer. In group 4, lambs with cryptosporidiosis were subjected to normal feeding as control without drug administration. Clinical examinations of lambs were made before treatment (day 0) and on days 1, 3, 5 and 7 after treatment and 5 ml of blood was collected from vena jugularis for blood analysis of all lambs. Weight changes of lambs were recorded at 0, 7, 14, and 21 days. Stool specimens were collected pre-treatment (day 0) and on days 1, 3, 5, 7, 14 and 21 post-treatment to determine oocyst excretion of lambs with cryptosporidiosis. Lambs with a mean oocyte counts >10 after stool examination were included to the treatment. Changes in clinical hematology, blood gases and biochemical parameters were observed during the course of treatment, but these changes were limited. Weight loss was observed at 7th day according to 0th day the lambs with experimental cryptosporidiosis but gradually weight increase was observed at 14th and 21st days and these changes were similar in all groups. Oocyst excretion decreased in all groups during treatment. According to 0th day, there was a significant (p < 0.05) decrease in oocyte excretions in the third day in group 1 and 2, and in day 5 in the group 3 and 4. Significant changes (p < 0.05) were observed in oocyst excretions on the third and fifth days among the groups. As a result, in lambs with experimental cryptosporidiosis, chitosan oligosaccharide improved in clinical signs and stool character shorter than the positive control group and the administration of chitosan oligosaccharide at doses of 100, 500 and 1000 mg/kg for 7 days significantly reduced oocyst excretion but not enough to remove cryptosporidiosis completely.
format Online
Article
Text
id pubmed-7135297
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71352972020-04-08 The determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis Aydogdu, Ugur Coskun, Alparslan Atas, Ahmet Duran Basbug, Onur Agaoglu, Zahid Tevfik Small Rumin Res Article In this study, it was aimed to investigate the efficacy of chitosan oligosaccharide administrations in different doses of experimental infected lambs with Cryptosporidium parvum. 32 male lambs were used in the study and the lambs were divided into 4 groups with 8 lambs in each group. Groups 1, 2 and 3, twice a day, were administered chitosan oligosaccharide at a dose of 100, 500, and 1000 mg/kg for 7 days, respectively, with milk replacer. In group 4, lambs with cryptosporidiosis were subjected to normal feeding as control without drug administration. Clinical examinations of lambs were made before treatment (day 0) and on days 1, 3, 5 and 7 after treatment and 5 ml of blood was collected from vena jugularis for blood analysis of all lambs. Weight changes of lambs were recorded at 0, 7, 14, and 21 days. Stool specimens were collected pre-treatment (day 0) and on days 1, 3, 5, 7, 14 and 21 post-treatment to determine oocyst excretion of lambs with cryptosporidiosis. Lambs with a mean oocyte counts >10 after stool examination were included to the treatment. Changes in clinical hematology, blood gases and biochemical parameters were observed during the course of treatment, but these changes were limited. Weight loss was observed at 7th day according to 0th day the lambs with experimental cryptosporidiosis but gradually weight increase was observed at 14th and 21st days and these changes were similar in all groups. Oocyst excretion decreased in all groups during treatment. According to 0th day, there was a significant (p < 0.05) decrease in oocyte excretions in the third day in group 1 and 2, and in day 5 in the group 3 and 4. Significant changes (p < 0.05) were observed in oocyst excretions on the third and fifth days among the groups. As a result, in lambs with experimental cryptosporidiosis, chitosan oligosaccharide improved in clinical signs and stool character shorter than the positive control group and the administration of chitosan oligosaccharide at doses of 100, 500 and 1000 mg/kg for 7 days significantly reduced oocyst excretion but not enough to remove cryptosporidiosis completely. Elsevier B.V. 2019-11 2019-09-27 /pmc/articles/PMC7135297/ /pubmed/32288211 http://dx.doi.org/10.1016/j.smallrumres.2019.09.021 Text en © 2019 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Aydogdu, Ugur
Coskun, Alparslan
Atas, Ahmet Duran
Basbug, Onur
Agaoglu, Zahid Tevfik
The determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis
title The determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis
title_full The determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis
title_fullStr The determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis
title_full_unstemmed The determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis
title_short The determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis
title_sort determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135297/
https://www.ncbi.nlm.nih.gov/pubmed/32288211
http://dx.doi.org/10.1016/j.smallrumres.2019.09.021
work_keys_str_mv AT aydogduugur thedeterminationoftreatmenteffectofchitosanoligosaccharideinlambswithexperimentallycryptosporidiosis
AT coskunalparslan thedeterminationoftreatmenteffectofchitosanoligosaccharideinlambswithexperimentallycryptosporidiosis
AT atasahmetduran thedeterminationoftreatmenteffectofchitosanoligosaccharideinlambswithexperimentallycryptosporidiosis
AT basbugonur thedeterminationoftreatmenteffectofchitosanoligosaccharideinlambswithexperimentallycryptosporidiosis
AT agaogluzahidtevfik thedeterminationoftreatmenteffectofchitosanoligosaccharideinlambswithexperimentallycryptosporidiosis
AT aydogduugur determinationoftreatmenteffectofchitosanoligosaccharideinlambswithexperimentallycryptosporidiosis
AT coskunalparslan determinationoftreatmenteffectofchitosanoligosaccharideinlambswithexperimentallycryptosporidiosis
AT atasahmetduran determinationoftreatmenteffectofchitosanoligosaccharideinlambswithexperimentallycryptosporidiosis
AT basbugonur determinationoftreatmenteffectofchitosanoligosaccharideinlambswithexperimentallycryptosporidiosis
AT agaogluzahidtevfik determinationoftreatmenteffectofchitosanoligosaccharideinlambswithexperimentallycryptosporidiosis